Publications
Export 12 results:
Filters: Author is Stip, Emmanuel [Clear All Filters]
, “Antipsychotic utilization trajectories three years after initiating or reinitiating treatment of schizophrenia: A state sequence analysis approach”, Acta Psychiatrica Scandinavica, vol. 145, no. 5, pp. 469 - 480, 2022.
“Association between previous and future antipsychotic adherence in patients initiating clozapine: real-world observational study.”, Br J Psychiatry, pp. 1-8, 2022.
“Comparative effectiveness and safety of antipsychotic drugs in patients with schizophrenia initiating or reinitiating treatment: A Real-World Observational Study.”, Acta Psychiatr Scand, vol. 145, no. 5, pp. 456-468, 2022.
“[Psychopharmacology of First Episode Psychosis: An Approach Based on Recovery].”, Sante Ment Que, vol. 46, no. 2, pp. 113-137, 2021.
, “Urbanicity, Schizophrenia and Equitable Specialist Services Allocation.”, Can J Psychiatry, p. 7067437211040606, 2021.
, “From QAAPAPLE 1 to QAAPAPLE 2: How do we move from one algorithm to another one with Long acting antipsychotics (LAIs).”, Expert Rev Neurother, 2020.
, “[Long-acting antipsychotics: The QAAPAPLE algorithm review].”, Can J Psychiatry, p. 706743719847193, 2019.
, “An Exploratory, Open-Label, Randomized Trial Comparing Risperidone Long-Acting Injectable with Oral Antipsychotic Medication in the Treatment of Early Psychosis.”, Clin Schizophr Relat Psychoses, vol. 9, no. 4, pp. 198-208, 2016.
, “[Long-acting injectable antipsychotics: an expert opinion from the Association des médecins psychiatres du Québec].”, Can J Psychiatry, vol. 56, no. 6, pp. 367-76, 2011.
, “Anhedonia and social adaptation predict substance abuse evolution in dual diagnosis schizophrenia.”, Am J Drug Alcohol Abuse, vol. 34, no. 1, pp. 75-82, 2008.
, “Endogenous cannabinoids in patients with schizophrenia and substance use disorder during quetiapine therapy.”, J Psychopharmacol, vol. 22, no. 3, pp. 262-9, 2008.
, “Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial.”, Curr Med Res Opin, vol. 22, no. 7, pp. 1277-85, 2006.
